Proteolysis and deglycosylation of human C1 inhibitor. Effect on functional properties
- PMID: 3311024
- PMCID: PMC1147961
- DOI: 10.1042/bj2440117
Proteolysis and deglycosylation of human C1 inhibitor. Effect on functional properties
Abstract
The effects of proteolysis and deglycosylation on C1 inhibitor (C1Inh) were tested with respect to both its ability to form complexes with C1s and its capacity to block C1 autoactivation. Limited proteolysis of C1Inh by Staphylococcus aureus V8 proteinase, proline-specific endopeptidase or elastase generated a major high-Mr (approximately 86,000) fragment. In contrast with the fragment produced by elastase, which was inactive, the fragments resulting from V8 proteinase and proline-specific endopeptidase treatment retained activity. Deglycosylation with N-glycanase or O-glycanase, or both, had no major effect on the functional activity of C1Inh.
Similar articles
-
Enzymatic inactivation of human plasma C1-inhibitor and alpha 1-antichymotrypsin by Pseudomonas aeruginosa proteinase and elastase.Biochim Biophys Acta. 1984 Aug 28;789(1):37-43. doi: 10.1016/0167-4838(84)90057-8. Biochim Biophys Acta. 1984. PMID: 6432051
-
C1 subcomponent complexes: basic and clinical aspects.Behring Inst Mitt. 1993 Dec;(93):292-8. Behring Inst Mitt. 1993. PMID: 8172579 Review.
-
A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.J Clin Invest. 1988 Aug;82(2):700-5. doi: 10.1172/JCI113650. J Clin Invest. 1988. PMID: 2457036 Free PMC article.
-
Expression of functional human C1 inhibitor in COS cells.J Biol Chem. 1988 Aug 25;263(24):11776-9. J Biol Chem. 1988. PMID: 2841334
-
Electron microscope studies of C1s, C1s2, C1r2, C1r2C1s2 and C1-inhibitor.Behring Inst Mitt. 1993 Dec;(93):17-24. Behring Inst Mitt. 1993. PMID: 8172564 Review. No abstract available.
Cited by
-
Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis.Front Cardiovasc Med. 2022 May 3;9:878199. doi: 10.3389/fcvm.2022.878199. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35592395 Free PMC article. Review.
-
A New Tool for Complement Research: In vitro Reconstituted Human Classical Complement Pathway.Front Immunol. 2018 Dec 4;9:2770. doi: 10.3389/fimmu.2018.02770. eCollection 2018. Front Immunol. 2018. PMID: 30564230 Free PMC article.
-
N-linked glycosylation is required for c1 inhibitor-mediated protection from endotoxin shock in mice.Infect Immun. 2004 Apr;72(4):1946-55. doi: 10.1128/IAI.72.4.1946-1955.2004. Infect Immun. 2004. PMID: 15039314 Free PMC article.
-
N-linked glycosylation at Asn3 and the positively charged residues within the amino-terminal domain of the c1 inhibitor are required for interaction of the C1 Inhibitor with Salmonella enterica serovar typhimurium lipopolysaccharide and lipid A.Infect Immun. 2005 Aug;73(8):4478-87. doi: 10.1128/IAI.73.8.4478-4487.2005. Infect Immun. 2005. PMID: 16040958 Free PMC article.
-
N- and O-glycosylation Analysis of Human C1-inhibitor Reveals Extensive Mucin-type O-Glycosylation.Mol Cell Proteomics. 2018 Jun;17(6):1225-1238. doi: 10.1074/mcp.RA117.000240. Epub 2017 Dec 12. Mol Cell Proteomics. 2018. PMID: 29233911 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous